GRP
ABCL icon

Global Retirement Partners’s AbCellera Biologics ABCL Stock Holding History

Global Retirement Partners’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$5.86K Hold
2,000
– – ﹤0.01% 2620
2024
Q3 		$5.2K Hold
2,000
– – ﹤0.01% 2544
2024
Q2 		$5.92K Hold
2,000
– – ﹤0.01% 2542
2024
Q1 		$9.06K Buy
2,000
+1,584
+381% +$8.08K ﹤0.01% 2164
2023
Q4 		$2.08K Hold
416
– – ﹤0.01% 2656
2023
Q3 		$1.84K Hold
416
– – ﹤0.01% 2568
2023
Q2 		$2.69K Hold
416
– – ﹤0.01% 2428
2023
Q1 		$2.74K Sell
416
-208
-33% -$1.89K ﹤0.01% 2387
2022
Q4 		$6.32K Buy
+624
New +$7.21K ﹤0.01% 1944

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Global Retirement Partners's ABCL Position: Q4 2024 in Review

Global Retirement Partners held its AbCellera Biologics (ABCL) position steady in Q4 2024 at 2,000 shares worth $5.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Global Retirement Partners first reported a position in ABCL in Q4 2022 and has held it in 9 quarters since. The position peaked at $9.06K in Q1 2024. 146 funds tracked by Wall St. Rank hold ABCL as of Q4 2024.

  • Global Retirement Partners held 2,000 shares of AbCellera Biologics worth $5.86K as of Q4 2024.
  • Global Retirement Partners left its AbCellera Biologics share count unchanged in Q4 2024.
  • AbCellera Biologics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #2620 holding.
  • Global Retirement Partners first reported a position in AbCellera Biologics in Q4 2022 and has held it in 9 quarters since.
  • Global Retirement Partners's AbCellera Biologics position peaked at $9.06K in Q1 2024.
  • 146 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.